© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Long before most folks worried about antibiotic resistance, scientists looked for compounds to treat eye infections that were running rampant. Sulfacetamide emerged from that crucible of necessity. Chemists first introduced it in the early 20th century, as they searched among sulfonamide derivatives for safer antimicrobial agents. Early ophthalmology journals gave Sulfacetamide Sodium Monohydrate attention because it handled bacteria well where older treatments failed. Over time, the world saw this compound make its mark in clinics and pharmacies from New York to Tokyo, a quiet staple in medical practice long before pharmaceutical giants churned out broader-spectrum drugs.
Sulfacetamide Sodium Monohydrate stands out as a synthetic sulfonamide antibiotic, often packed as an off-white, odorless powder. It finds its place mostly in ophthalmic solutions, creams, and topical preparations. Pharmaceutical companies favor its stability and solubility. Patients dealing with conjunctivitis, blepharitis, or skin infections recognize the name as a prescription that actually calms the storm of bacterial irritation. As a finished product, it promises moderate cost, ready availability, and no need for elaborate handling—making it a firm favorite for thousands of clinics and small-town hospitals alike.
A closer look reveals why Sulfacetamide Sodium Monohydrate works so well in medical settings. Its molecular formula—C8H9N2NaO4S·H2O—shows a structure tailored for water solubility, which translates to quick action in biological fluids. Pure samples present as crystalline powder, melting above 200°C, with a pH behavior that keeps it gentle on tissues but potent against harmful microbes. Manufacturers like reliable density, clear handling protocols, and consistent solubility at therapeutic concentrations. These qualities explain why the chemical often lands in eye-care products—no one wants grainy residue scratching an infected cornea.
Every bottle or tube of sulfacetamide comes with tightly controlled specifications. Pharmacopeias list its minimum required purity, usually above 98%, and labs routinely measure for impurities, because even trace contamination can risk patient safety. Labels give concentrations in percentage weight by volume or weight by weight, depending on use. Batch release sheets list pH, assay results, and sterility checks. Regulations insist that storage and expiration dates reflect real shelf-life, with clear instructions for dose frequency, and contraindications for those allergic to sulfa drugs. These measures come from years of mishaps, recalls, and rare allergic reactions, so manufacturers and pharmacists alike keep the documentation tight.
The chemical route to sulfacetamide sodium monohydrate usually begins with the reaction of acetanilide with chlorosulfonic acid, creating sulfacetamide’s core structure. Experts add sodium hydroxide, transforming the compound into its sodium salt for easy formulation. Proper hydration gives the monohydrate version, which meets solubility requirements for eye drops. Batch processes run in controlled reactors, with purification phases using crystallization and filtration to catch every impurity. Final drying, milling, and blending take place under strict environmental standards, as cross-contamination can’t be tolerated in ophthalmic-grade products. My own stint in a pharmaceutical analytical lab taught me the critical steps: one wrong temperature or unfiltered air sample, and a whole batch could wind up in waste.
Most modern chemistry labs don’t stop at simple sodium salt formation. Recent work explores prodrug forms, which release sulfacetamide slowly, aiming for longer-lasting relief in chronic infections. Some teams experiment with blending sulfacetamide derivatives with polymer carriers, hoping for better adhesion to mucous membranes. Others jazz up the molecule for extended antimicrobial spectra, hoping to bypass growing resistance. These tweaks push regulatory headaches to new heights, but the promise of fewer daily doses and better tolerability keeps researchers busy.
Walk into a pharmacy, and you might not always see “Sulfacetamide Sodium Monohydrate” spelled out. Instead, you’ll find names like “Bleph-10,” “Sulph-20,” or “Sulfacetamide Sodium Ophthalmic Solution USP.” In laboratory texts, it pops up as N-Acetylsulfanilamide sodium salt hydrate or by codes like CAS 6209-17-2. Healthcare workers need to keep track of synonyms across brands and generics so mistakes in substitution don’t happen. Patients sometimes know it only as the “sulfa eye drops” their grandmothers used. This wide naming spectrum sometimes confuses new practitioners, but it shows the long-running popularity and enduring trust in the product.
Production follows a tight rulebook. Workers suit up to avoid inhaling powder or letting it contact the skin, as some develop rashes or even systemic allergic reactions from repeated exposure. Medical staff caution patients about sulfa allergies, and prescription forms always flag known interactions. Labs invest in closed ventilation, dust collectors, and spill containment—not out of paranoia, but from real incidents where inattentive handling led to exposure. Even disposal protocols get scrutiny, since sulfonamides can bother aquatic ecosystems if local wastewater systems lack advanced filtration. At every point, the ethos of “safety by design” sticks, informed by decades of workplace monitoring and patient case reports.
Sulfacetamide Sodium Monohydrate made its name fighting bacterial eye and skin infections. Thousands of kids with gunky conjunctivitis or adults with styes got better thanks to timely drops or ointments. In dermatology, it partners with corticosteroids in creams for acne rosacea and seborrheic dermatitis. Occasionally, it finds use in research as a reference antibiotic, helping scientists test the sensitivity of new bacterial strains. Outside medicine, you’ll see it pop up in veterinary care, for the treatment of companion animals suffering eye or wound infections—a testament to its gentle profile and reliability.
Modern researchers keep Sulfacetamide sodium monohydrate on the table for several reasons. Clinical pharmacists worry that resistance among Staphylococcus and Streptococcus species could limit its future. Technicians run susceptibility tests in hospitals, feeding results into giant surveillance networks. R&D teams mix the drug with peptides, nanoparticles, or slow-release hydrogels, seeking to defeat chronic biofilms or extend dosing intervals. In academic circles, labs explore its molecular interactions with bacterial folic acid pathways, mapping how resistance genes change the protein targets. These studies generate papers, patents, and the promise of new application forms—though regulatory approval remains notoriously slow.
No discussion about sulfacetamide can skip its risks. Toxicity studies, both historical and modern, show that most patients tolerate normal topical doses well. Still, folks with a sulfonamide allergy face a real chance of rash, fever, or rare but deadly Stevens-Johnson syndrome. Modern animal studies and human monitoring focus on chronic low-dose exposure, especially in sensitive pediatric or pregnant populations. Accidental oral ingestion, though uncommon, prompts poison control guidance, as high doses can affect red blood cells, kidneys, and the central nervous system. Regulators and practitioners weigh these risks against declining alternatives, as superbugs close therapeutic doors that once stood wide open.
The story of sulfacetamide is not stuck in the past. As resistance nibbles at modern antibiotics, some researchers revisit older, narrower-spectrum drugs with a fresher lens. Pharmaceutical firms consider reformulations—eye drops with better preservatives, creams mixed with anti-inflammatories, and low-cost generics for regions facing new bacterial threats. AI-driven drug design tools scan its structure for new derivatives with improved safety windows. Public health agencies invest in global surveillance, weighing the balance between overuse and access. Whether sulfacetamide will reclaim center stage or quietly retire to smaller roles depends as much on the choices we make as on new chemistry. My own experience says putting patients first—through rigorous monitoring, continued education, and honest reporting—will decide how this humble compound continues to serve well into the next century.
Anyone who’s suffered through burning, itching eyes or a stubborn skin infection knows that relief can’t come soon enough. That’s where medications like sulfacetamide sodium monohydrate often step in. It’s not as well-known as penicillin or ibuprofen, but it has been quietly helping people manage bacterial infections for decades.
Plenty of folks first hear about sulfacetamide sodium monohydrate after a trip to the eye doctor for conjunctivitis. Red, irritated eyes send people looking for answers, and the diagnosis lands them a bottle of sulfacetamide eye drops or ointment. Eye infections like “pink eye” usually result from bacteria making themselves at home on your conjunctiva. Here’s where sulfacetamide gets to work: it blocks the ability of bacteria to use folic acid, which stops them from growing and spreading. With proper use, symptoms start to ease up in a couple of days, giving people a real sense of relief without resorting to stronger, broad-spectrum antibiotics.
This medication shows up in dermatology offices, too. Many teens, and plenty of adults, know the frustration of acne that just won’t quit. Dermatologists might reach for sulfacetamide sodium monohydrate creams or washes to fight acne, seborrheic dermatitis, and rosacea. Since a lot of acne comes from blocked pores infected with bacteria, the compound’s antibacterial action can help clear things up over time. Unlike some old-school antibiotics, sulfacetamide brings fewer worries about resistance when used as directed in topical treatments. In my own family, a relative used a sulfacetamide-based cream after trying nearly everything else. The change in their skin happened gradually, but they finally saw breakouts shrink and inflammation settle. That confidence booster made a real difference at school and work.
No medication works perfectly for everyone. Some people run into allergies—especially anyone with a sulfa allergy. Doctors check for that before suggesting sulfacetamide, but even then, a rash or mild irritation can catch users off guard. Most people tolerate it well, though, and side effects rarely push users to stop treatment altogether. Compared to more powerful antibiotics, sulfacetamide sodium monohydrate poses less risk of triggering resistance, and that’s become a huge public health concern. Overuse of antibiotics could let bacteria outsmart our medicines, so sticking with focused medications like this makes sense.
Pediatricians and dermatologists choose sulfacetamide because it gets the job done without the baggage of stronger drugs. It’s been around for decades and its track record shows it often works where gentle, routine care falls short. That builds trust not just with doctors, but with patients who want straightforward treatments without scary side effects.
The real value shows up when people use sulfacetamide as prescribed and finish a course, even if symptoms improve fast. Skipping doses or dropping off early opens the door for leftover bacteria to build up defenses. Make follow-up appointments, especially for recurring infections, and let healthcare providers know about any side effects. Reading up on prescription directions and getting questions answered up front can make every treatment go smoother.
Medications like sulfacetamide sodium monohydrate might never become household names. Still, they quietly support people dealing with irritating, sometimes embarrassing infections. As ideas about antibiotic stewardship keep growing, using time-tested tools in a careful, targeted way will keep these humble medications available for the next patient searching for relief.
Sulfacetamide sodium monohydrate often shows up in topical treatments for bacterial skin conditions such as acne, seborrheic dermatitis, and certain eye infections. This medicine tackles bacteria by blocking the way they make the substances they need to survive. Over my career and through conversations with pharmacists, I have seen patients grow frustrated when products don’t work, only to learn they weren’t using them how doctors intended.
Every type of this medication—creams, lotions, solutions—calls for application on clean, dry skin. Many people don’t realize that soap residue or lingering makeup causes the active ingredient to struggle. Rinsing the skin with lukewarm water and patting it dry helps make sure the medicine stays in contact long enough to do its work. The same applies to eye drops: clear away any discharge, then wash your hands before breaking open the bottle for each dose.
I remember my teenage years, swiping pimples with thick layers of whatever spot medicine seemed promising. More wasn’t better. A thin layer covers enough surface without wasting the product or risking irritation. Dermatologists I’ve spoken to tell patients to use just enough for a light, even coat over affected areas, not slathering it all over healthy skin. Too much medication builds up and causes redness or stinging, which can scare people off treatment unnecessarily.
Doctors usually want this medicine applied one to three times a day. Schedules can get tricky in between jobs, meals, and classes. I’ve watched family members forget midday doses or overuse it before a big date, then wonder why their skin turned flaky. Setting alarms and keeping medication next to the toothbrush or makeup bag helps anchor the habit into the daily routine.
Missed a dose? I remind folks not to double up, which just piles on irritation. Wait for the next scheduled time and pick up the routine as usual. If using drops, I find pressing gently at the corner of the eye with a clean finger after putting them in lets the medicine soak in and keeps it from running out onto the cheek.
Many parents call their doctor, worried about a child’s rash worsening after starting treatment. This often comes from putting medication on cracked or broken skin, which can sting. A steady, consistent application on intact skin tends to show improvement within days to weeks, depending on the condition. If nothing changes after that, or if unusual swelling or pain pops up, it’s time to call the prescriber.
Reading labels carefully matters. Eye solutions should not touch contact lenses. Most products work best away from sensitive areas like lips or open wounds. Direct sunlight makes treated skin sensitive, so a hat and sunscreen aren’t optional—they’re part of getting better.
Sulfacetamide sodium monohydrate offers relief if someone follows the guidance—clean skin, regular dosing, careful application. Pharmacists and doctors know the tricks for safer use. Listen to their advice and ask about anything that doesn’t seem right. The path to clearer skin or healthier eyes isn’t always quick, but the right approach makes progress much more likely.
Sulfacetamide sodium monohydrate often lands on a doctor’s prescription pad for eye infections. It’s a sulfa-based antibiotic, a familiar choice for treating pink eye and other bacterial issues. Over years of talking with pharmacists and reading scientific journals, I’ve seen patients use it, sometimes feeling relief, sometimes coming in with concerns.
Using any eye drop comes with risks. For sulfacetamide sodium monohydrate, the main complaints show up right after use: burning, stinging, or mild redness. Eyes can feel gritty, or vision may blur for a few moments. Most of these reactions happen on day one. They don’t always stop folks from using the drops, especially if infection symptoms fade quickly. Still, doctors pay attention if irritation sticks around or gets worse. The American Academy of Ophthalmology lists these as common, and, in my experience, patients often need reassurance that these sensations pass.
Every so often, more serious side effects turn up. Allergic reactions are rare but deserve attention. Signs include swelling of the eyelid or around the eye, itching, or a rash beyond the treated area. If trouble breathing, hives, or swelling of the face or tongue happens, emergency care matters most. In a clinic where I shadowed, the staff always reminded patients that allergies develop even after years of safe use, especially with sulfa medications.
Some people react to sulfa drugs more than others. Anyone with a known sulfa allergy skips sulfacetamide sodium monohydrate altogether. People with sensitive skin may notice more eyelid swelling. Infants and young children handle medications differently, and older adults may report more dryness or irritation. Personal health history, especially of allergic reactions, helps the doctor decide if this antibiotic makes sense for you.
Doctors keep courses short because overuse leads to other problems. Prolonged use sometimes encourages fungal or secondary bacterial infections—resistance grows, healthy bacteria vanish, and the door opens to new germs. I remember a case where the doctor stopped the drops once vision improved to avoid these risks. Published studies remind us that overuse causes more harm than good.
People with chronic eye problems, like glaucoma, check in with the ophthalmologist before using new eye drops. Sulfacetamide sodium monohydrate sometimes interacts with other treatments. Clear communication between patient and doctor does more for safety than a printed warning sheet at the pharmacy ever will.
Doctors suggest using the drops for the full course, but not longer. Washing hands before and after applying the medicine, avoiding touching the eye with the tip, and sharing symptoms with your provider all go a long way. Reading the side effect list in the product leaflet helps patients know when to call for help. For every ten worried calls I've received as a health worker, at least half came from confusion about whether a symptom was normal or not.
Research from organizations like the National Institutes of Health supports keeping antibiotic use thoughtful: short courses, correct storage, and regular eye checks at the doctor’s office so that unwanted effects stay rare.
Pregnancy and breastfeeding bring along worries around what’s safe for the baby. People start wondering about everything, from the snacks they eat to the medicine the doctor recommends. Even eye drops or creams that carry a medical-sounding name like sulfacetamide sodium monohydrate fall under this microscope, especially if someone’s doctor scribbles it on a prescription pad during pregnancy or after delivery.
Sulfacetamide sodium monohydrate sits among the sulfonamide family—a group of antibiotics used mostly for skin and eye infections. It works against bacteria by stopping them from growing, which sounds like a simple fix for some irritating problems. Obstetricians acknowledge it comes in handy, but the main question boils down to risk. Will exposure hurt the growing baby or affect breastfeeding?
The Food and Drug Administration sorts medicines into categories for use during pregnancy. Sulfacetamide landed in category C, meaning animals showed some effects on developing babies, but clear evidence in humans doesn’t exist. Doctors look at situations case by case, and try to weigh whether clearing up a stubborn eye or skin issue outweighs the potential harm. Many times, they recommend something else, but sometimes the infection won’t budge any other way.
During my time volunteering at a women’s health clinic, nervous mothers-to-be called often. They’d ask about every pill and ointment, especially after seeing warning labels or doom-laden web forums. One mother struggled with a recurring eye infection that just wouldn’t clear. She’d cycled through warm compresses, different drops, and was at her wit’s end. Psychologically, constant discomfort takes a toll—nobody needs that during pregnancy.
Her doctor weighed options and finally prescribed sulfacetamide eye drops for a short burst, warning her to use just as directed and to report anything unusual right away. She recovered. It helped to talk openly, hear about the risks and benefits, and focus on not just the pregnancy, but the mother's health too. Dead set avoidance can sometimes backfire—serious infection risks the health of mom and baby even more.
Breastfeeding mothers land in the same dilemma. Research points to low levels of sulfacetamide entering breast milk when used in forms like skin creams or eyedrops, not pills. Studies show the baby absorbs very little, and most healthy, full-term infants handle it fine. If a newborn has certain rare blood issues, the calculus changes. Doctors ask more detailed questions in these cases. No medication gets the green light without a look at the whole picture.
Medicine never lives in a bubble—decisions end up more complicated than any black-and-white answer. Doctors need to talk up front about any concerns. Pharmacists can help double-check. Reading the label at home, asking follow-ups, and not relying on search results alone leads to better outcomes. Real world experience says people deserve facts, not just lists of warnings. That means bringing concerns to the doctor and balancing what’s needed for the mother's comfort and the baby’s safety.
The best way to move forward always rests on solid communication: open questions, honest answers, and weighing real risk against real benefit. That gives families and new mothers some breathing room and clarity, when there are already plenty of things to worry about.
Sulfacetamide sodium monohydrate turns up on pharmacy shelves as an old-school antibiotic, fighting everything from pink eye to some stubborn skin conditions. The idea that you might want to grab a tube or bottle without a trip to your healthcare provider isn’t surprising — who wouldn’t want a shortcut when an irritating rash flares up? But medicine and shortcuts rarely mix well, and Sulfacetamide sodium monohydrate stands as no exception in the United States and most developed countries.
Sulfacetamide sodium, whether in drops, creams, or lotions, comes under the FDA’s umbrella of prescription-only medications in America. The logic is straightforward: doctors want to be sure folks dealing with bacterial conjunctivitis, seborrheic dermatitis, or acne rosacea get the real deal for their specific issue — not just a shot in the dark because a neighbor swears by it. This kind of approach cuts down on accidental misuse, dangerous allergies, and worsening infection from using the wrong medication. It’s not sold over the counter in U.S. pharmacies, even for recurring conditions.
Some may look at prescription barriers as a headache, yet real problems crop up when antibiotics get used without supervision. I’ve seen people left with nasty rashes after they borrowed a tube from a friend, convinced their symptoms matched up. Without a proper diagnosis, the infection might not be bacterial, or it might be a bug that’s become resistant to certain treatments. Resistant infections upset families, fill hospitals, and make treating simple problems a lot tougher.
Research backs this up. As antibiotic misuse spreads, bacteria learn how to dodge these medicines more easily. A study from the CDC shows antibiotics get prescribed up to 30% more often than really necessary. The same goes for topical antibiotics. So, the prescription rule isn’t just red tape — it serves everyone’s health.
Consider eye infections. Sulfacetamide sodium often treats bacterial conjunctivitis (that familiar childhood “pink eye”), but not all red eyes come from bacteria. Some result from viruses, allergies, or even dirt. Using an antibiotic when you don’t need it can waste precious time and let a treatable infection turn nasty, sometimes causing irreversible eye damage. Diagnosis needs more than a Google image search — a real exam protects your sight.
People with poor access to care sometimes resort to self-medicating. This isn’t just risky — it widens health gaps. Pharmacists can play a bigger part here. In some countries, they have the authority to prescribe for minor infections after a quick check, freeing up doctors and making care faster. This model could help U.S. patients without putting public health at risk.
If you think you need sulfacetamide sodium monohydrate, call your healthcare provider, or visit a clinic. Telehealth services now make it easier to reach a professional from home. This protects your health and slows down antibiotic resistance. Sticking to prescription rules means every patient stands a better chance against infection—today and for years down the line.
| Names | |
| Preferred IUPAC name | sodium; 4-acetamidobenzenesulfonate; monohydrate |
| Other names |
Sulfacetamide sodium hydrate Monosodium sulfanilamide acetate monohydrate Sodium N-[(4-aminophenyl)sulfonyl]acetamide monohydrate |
| Pronunciation | /ˌsʌl.fəˈsɪ.tə.maɪd ˈsoʊ.di.əm ˌmɒn.oʊˈhaɪ.dreɪt/ |
| Identifiers | |
| CAS Number | 6209-17-2 |
| Beilstein Reference | 3566312 |
| ChEBI | CHEBI:9122 |
| ChEMBL | CHEMBL1200605 |
| ChemSpider | 173977 |
| DrugBank | DB00628 |
| ECHA InfoCard | 03e6dcd9-2a37-4edb-913e-e01d10b0ad2e |
| EC Number | 222-193-1 |
| Gmelin Reference | 87135 |
| KEGG | C07436 |
| MeSH | D013206 |
| PubChem CID | 23667581 |
| RTECS number | WT0680000 |
| UNII | Z9UQ4UBM7K |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C8H9N2NaO4S·H2O |
| Molar mass | 288.28 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | Density: 1.49 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -3.0 |
| Acidity (pKa) | 9.2 |
| Basicity (pKb) | 6.50 |
| Magnetic susceptibility (χ) | -64.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.627 |
| Dipole moment | 3.98 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 296.8 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | S01AB04 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory irritation. Harmful if swallowed. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Store away from strong oxidizing agents. Avoid contact with eyes, skin, and clothing. Use with adequate ventilation. Do not ingest or inhale. Wash thoroughly after handling. |
| NFPA 704 (fire diamond) | 2-1-2 |
| Explosive limits | Non-explosive |
| Lethal dose or concentration | LD₅₀ (oral, rat): 16,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral (rat): 16,000 mg/kg |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1 g |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds |
Sulfacetamide Sulfacetamide Sodium Sulfacetamide Sodium Anhydrous Sulfanilamide Sulfachlorpyridazine Sulfaquinoxaline Sulfamethoxazole |
